Celea Therapeutics vs Enterome
Celea Therapeutics vs Enterome, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Celea Therapeutics is on 53/100 and Enterome on 60/100.
Where each one leads
Celea Therapeutics
- agent readiness: 39/100 against 21/100
- headcount: 83 against 33
- funding raised: $360M against $124M
Enterome
- our overall score: 60/100 against 53/100
- LinkedIn following: 16,846 against 12,190
At a glance
| Measure | Celea Therapeutics | Enterome |
|---|---|---|
| What it is | Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF). | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. |
| Category | Biotechnology, Pharmaceuticals, HealthTech, Biotech | Biotechnology, Drug Discovery, Oncology, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software | hardware | services | marketplace | platform |
| Founded | Not published | 2012 |
| Headquarters | Boston, USA | Paris, France |
| Status | Active | Active |
Size, funding and growth
| Measure | Celea Therapeutics | Enterome |
|---|---|---|
| Employees | 83 | 33 |
| Total funding | $360M | $124M |
| Latest round | Funding Round | Later Stage VC |
| LinkedIn followers | 12,190 | 16,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Celea Therapeutics | Enterome |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 60/100 |
| Traction | 59/100 | 55/100 |
| Team | Not published | 70/100 |
| Search visibility | 22/100 | 34/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 48/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Celea Therapeutics | Enterome |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4, Segment |
Celea Therapeutics vs Enterome: common questions
Which is better, Celea Therapeutics or Enterome?
On our 0-100 score Enterome rates higher (60/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Celea Therapeutics and Enterome compare on the numbers?
Celea Therapeutics leads on agent readiness (39/100 against 21/100), headcount (83 against 33), funding raised ($360M against $124M). Enterome leads on our overall score (60/100 against 53/100), LinkedIn following (16,846 against 12,190).
Read the full Celea Therapeutics review and pricing or the Enterome review and pricing. You can also browse other Celea Therapeutics alternatives we track.